Elscint
This article was originally published in The Gray Sheet
Executive Summary
Haifa, Israel-based manufacturer of diagnostic imaging systems enters private placement agreements with "a number of Israeli institutional investors" for the sale of 3 mil. new "ordinary shares" of Elscint stock at $7.40 per share. As of Dec. 31, Elscint had 76.3 mil. shares outstanding.